Search Results
The product title you are looking for is no longer available. Other similar products that may interest you are listed below:
Results for 'Cytogenetics' |
| Title | Publication Date | Price | Relevance |
|---|---|---|---|
|
Cytogenetics Technologies,Markets and Companies |
May 2009 | £1220 | 100 % |
|
Cytogenetics, FISH and Molecular Testing in Hematologic Malignancies |
January 2008 | £110 | 94 % |
|
Myeloproliferative Disorders: Biology and Management |
October 2007 | £105 | 20.3 % |
|
Bio-Reference Laboratories, Inc. - Financial and Strategic Analysis Review |
June 2009 | £76 | 20 % |
|
Stakeholder Opinions: Acute Leukemias Persistent unmet needs confer significant commercial opportunity |
April 2006 | £2170 | 19.95 % |
|
Molecular Diagnostics A Dynamic and Rapidly Broadening Market Overview |
January 2009 | £2290 | 17.5 % |
|
Multiple Myeloma |
October 2007 | £105 | 16.1 % |
|
HighGrowth Diagnostic Markets |
November 2008 | £2075 | 11.2 % |
|
High-Growth Diagnostic Testing Markets |
November 2008 | £2075 | 11.2 % |
|
Microscopy Markets |
July 2008 | £2075 | 7.35 % |
|
Molecular Diagnostics Markets |
September 2008 | £2075 | 6.65 % |
|
Stakeholder Insight: Chronic Leukemias Is there room left for improvement? |
November 2008 | £8000 | 3.85 % |
|
Molecular Diagnostics Technologies, Markets and Companies |
May 2009 | £2745 | 3.85 % |
|
Animal Biotechnology Technologies, Markets and Companies |
May 2009 | £1525 | 2.8 % |
|
What's Hot in Cancer Drug R&D? |
July 2006 | £295 | 2.45 % |





